- Home
- FIVE vs KYMR Comparison
FIVE vs KYMR Comparison
Compare FIVE & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FIVE | KYMR |
|---|---|---|
| Founded | 2002 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 10.6B |
| IPO Year | 2012 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FIVE | KYMR |
|---|---|---|
| Price | $221.30 | $104.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 25 | 23 |
| Target Price | ★ $310.48 | $138.64 |
| AVG Volume (30 Days) | ★ 938.0K | 658.9K |
| Earning Date | 09-02-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.65 | N/A |
| EPS | ★ 6.20 | N/A |
| Revenue | ★ $4,764,147,000.00 | $39,211,000.00 |
| Revenue This Year | $19.86 | $167.86 |
| Revenue Next Year | $9.26 | N/A |
| P/E Ratio | $35.67 | ★ N/A |
| Revenue Growth | ★ 22.90 | N/A |
| 52 Week Low | $138.18 | $55.26 |
| 52 Week High | $263.88 | $130.05 |
Technical Indicators
Market Signals| Indicator | FIVE | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 38.83 | 33.91 |
| Support Level | $218.08 | $99.52 |
| Resistance Level | $235.56 | $121.24 |
| Average True Range (ATR) | 9.03 | 4.66 |
| MACD | -2.18 | -1.23 |
| Stochastic Oscillator | 12.53 | 4.80 |
Price Performance
Historical ComparisonAbout FIVE Five Below Inc.
Five Below Inc is a specialty value retailer offering a broad range of trend-right, high-quality products loved by the kid and the kid in all of customers. The Company's edited assortment of products includes select brands and licensed merchandise. The Company also sells its merchandise on the internet, through the Company's e-commerce website and mobile app, offering home delivery and the option to buy online and pick up in store. Additionally, the Company sells merchandise through on-demand third-party delivery services to enable its customers to shop online and receive convenient delivery. It derives revenue from sales of the Company's merchandise to customers.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.